Ewing’s sarcoma, first diagnosed 18.3.1996, histologically verified, tumour resistant to both chemotherapy and radiotherapy. UKRAIN therapy started on 13 October 1997 [115].

	15.6.1999	1.2.2000
1.9.1997	1.9.1997	1.2.2001	1.2.2001

The patient, a 10 year-old girl, was treated in the high-risk arm of the EICESS 92 study. MRI examination of the pelvic region on 1.9.1997 showed progression in the cystic-edematous process. She was then treated with combined Ukrain and local hyperthermia therapy. The therapy series consisted of 15 mg Ukrain in an infusion with 250 ml glucose and 5 g vitamin C followed by local hyperthermia treatment. Treatment was administered every second day up to a total of 10 therapy sessions. MRI examination on 8.1.1998 showed no progression of the tumour. Subsequent therapy cycles caused regression of the tumour (see MRI on 15.6.1999 and 1.2.2000). MRI on 1.2.2001: Cystic residual defect in right femur as observed in previous examinations. No sign of a relapse or metastases.